AVROBIO, Inc. Gains 45.33%

Thu, May 18, 2023 at 07:44 PM

AVROBIO, Inc. (AVRO:NASDAQ) jumped higher at $0.84, a gain of 45.3%. On Thu, May 18, 2023, AVRO:NASDAQ hit a New 2-Week High of $0.84. The stock appeared on our News Catalysts scanner on Thu, May 18, 2023 at 04:00 PM in the 'BIOTECH' category. From Thu, May 04, 2023, the stock recorded 40.00% Up Days and 27.27% Green Days

The stock spiked on Fri, Feb 10, 2023 at $1.93 with a volume of 3M+.

About AVROBIO, Inc. (AVRO:NASDAQ)

Avrobio Inc is a clinical stage gene therapy company. It is engaged in the development of potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose.

Top 10 Gainers:

Enveric Biosciences Inc. (ENVB:NASDAQ), 136.96%
AVROBIO, Inc. (AVRO:NASDAQ), 45.33%
Wang & Lee Group Inc. (WLGS:NASDAQ), 44.7%
Sonder Holdings Inc. (SOND:NASDAQ), 41.37%
Eltek Ltd. (ELTK:NASDAQ), 36.96%
GSI Technology, Inc. (GSIT:NASDAQ), 35.78%
Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 34.31%
Cue Health Inc. (HLTH:NASDAQ), 29.72%
Stryve Foods Inc. (SNAX:NASDAQ), 29.5%
Urstadt Biddle Properties Inc. (UBP:NYSE), 28.44%